EA201001002A1 - Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре - Google Patents

Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре

Info

Publication number
EA201001002A1
EA201001002A1 EA201001002A EA201001002A EA201001002A1 EA 201001002 A1 EA201001002 A1 EA 201001002A1 EA 201001002 A EA201001002 A EA 201001002A EA 201001002 A EA201001002 A EA 201001002A EA 201001002 A1 EA201001002 A1 EA 201001002A1
Authority
EA
Eurasian Patent Office
Prior art keywords
solid
growth hormones
microcapsules containing
containing growth
internal
Prior art date
Application number
EA201001002A
Other languages
English (en)
Russian (ru)
Inventor
Жоэль РИШАР
Хелен Габриелла Балдассини
Рита Агостинетто
Луиза Де-Анджелис
Франтс Дешамп
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA201001002A1 publication Critical patent/EA201001002A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA201001002A 2007-12-21 2008-11-21 Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре EA201001002A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07024906 2007-12-21
PCT/EP2008/009849 WO2009080164A1 (en) 2007-12-21 2008-11-21 Solid lipid microcapsules containing growth hormone in the inner solid core

Publications (1)

Publication Number Publication Date
EA201001002A1 true EA201001002A1 (ru) 2011-06-30

Family

ID=40566364

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001002A EA201001002A1 (ru) 2007-12-21 2008-11-21 Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре

Country Status (15)

Country Link
US (1) US8729015B2 (https=)
EP (1) EP2231120B1 (https=)
JP (1) JP5773651B2 (https=)
KR (1) KR20100103846A (https=)
CN (1) CN101903014B (https=)
AR (1) AR069844A1 (https=)
AT (1) ATE514417T1 (https=)
AU (1) AU2008340785B8 (https=)
BR (1) BRPI0821359A2 (https=)
CA (1) CA2710062C (https=)
EA (1) EA201001002A1 (https=)
ES (1) ES2367093T3 (https=)
IL (1) IL206393A (https=)
WO (1) WO2009080164A1 (https=)
ZA (1) ZA201005167B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0821359A2 (pt) 2007-12-21 2015-06-16 Merck Patent Ges Mit Beschränkter Haftung Microcápsulas de lipídeos sólidas contendo hormônio de crescimento no núcleo sólido interno
WO2010017965A2 (en) * 2008-08-11 2010-02-18 Merck Serono S.A. SOLID LIPID MICROCAPSULES CONTAINING hGH
CN102370630B (zh) * 2010-08-11 2014-04-02 中国科学院过程工程研究所 重组人生长激素rhGH长效缓释微囊及其制备方法
PL3574897T3 (pl) 2011-11-18 2022-05-09 Regeneron Pharmaceuticals, Inc. Postać użytkowa o przedłużonym uwalnianiu zawierająca mikrocząstki białka polimerowego do stosowania w ciele szklistym oka w leczeniu naczyniowych zaburzeń oczu
JP6554493B2 (ja) 2014-06-24 2019-07-31 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス
KR101602138B1 (ko) 2014-11-21 2016-03-10 강원대학교산학협력단 염화칼슘 미세입자가 봉입된 온도 의존성 고체지질입자 및 그 제조방법
AU2016378743A1 (en) * 2015-12-22 2018-08-02 The Trustees Of Princeton University Process for encapsulating soluble biologics, therapeutics, and imaging agents
KR20170079409A (ko) * 2015-12-30 2017-07-10 한미약품 주식회사 지속형 인간 성장 호르몬 결합체의 신규 액상 제제
CN109380730B (zh) * 2017-08-09 2023-02-03 内蒙古伊利实业集团股份有限公司 微胶囊油脂及其制备方法
WO2019055539A1 (en) 2017-09-12 2019-03-21 Prudhomme Robert K CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME
US12357582B2 (en) 2017-11-03 2025-07-15 The Trustees Of Princeton University Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations
US12186436B2 (en) 2018-07-19 2025-01-07 The Trustees Of Princeton University Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents
US11731099B2 (en) 2018-07-20 2023-08-22 The Trustees Of Princeton University Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
US20200147032A1 (en) 2018-11-14 2020-05-14 Robert K. Prud'homme Dihydromyricetin hot melt extrusion formulations and methods for forming them
CN114240934B (zh) * 2022-02-21 2022-05-10 深圳大学 一种基于肢端肥大症的图像数据分析方法及系统
CN116571178B (zh) * 2023-05-11 2026-01-20 仲恺农业工程学院 一种蓝莓花色苷微胶囊的制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6068044A (ja) * 1983-09-24 1985-04-18 Tetsuo Kato 二重膜構造のマイクロカプセル
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
DK0463061T3 (da) * 1989-03-17 1993-07-12 Pitman Moore Inc Controlled-release tilførselsindretning til afgivelse af makromolekylære proteiner
CA2407154A1 (en) * 2000-04-27 2001-11-01 Verion, Inc Zero order release and temperature-controlled microcapsules and process for the preparation thereof
US6967028B2 (en) * 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
US20060088595A1 (en) * 2003-02-19 2006-04-27 Naoki Asakawa Dispersant for sustained release preparations
EP2040682B1 (en) * 2006-06-05 2017-07-26 DSM Nutritional Products AG Microcapsules with improved shells
BRPI0821359A2 (pt) 2007-12-21 2015-06-16 Merck Patent Ges Mit Beschränkter Haftung Microcápsulas de lipídeos sólidas contendo hormônio de crescimento no núcleo sólido interno

Also Published As

Publication number Publication date
KR20100103846A (ko) 2010-09-28
JP5773651B2 (ja) 2015-09-02
US8729015B2 (en) 2014-05-20
CA2710062C (en) 2016-05-31
IL206393A (en) 2015-06-30
CA2710062A1 (en) 2009-07-02
EP2231120A1 (en) 2010-09-29
JP2011506499A (ja) 2011-03-03
ZA201005167B (en) 2011-03-30
EP2231120B1 (en) 2011-06-29
BRPI0821359A2 (pt) 2015-06-16
US20100310649A1 (en) 2010-12-09
AR069844A1 (es) 2010-02-24
WO2009080164A1 (en) 2009-07-02
ATE514417T1 (de) 2011-07-15
ES2367093T3 (es) 2011-10-28
IL206393A0 (en) 2010-12-30
AU2008340785B8 (en) 2014-09-18
CN101903014B (zh) 2014-04-16
AU2008340785B2 (en) 2014-05-08
CN101903014A (zh) 2010-12-01
AU2008340785A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
EA201001002A1 (ru) Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре
PE20142332A1 (es) Metodo y formulacion para reducir la agregacion de una macromolecula bajo condiciones fisiologicas
WO2007117509A3 (en) High delivery rates for lipid based drug formulations, and methods of treatment thereof
EA200601761A1 (ru) Композиции в качестве адъювантов для усиления иммунных ответов на вакцины и способы их применения
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
NO20075136L (no) Nye liposompreparater
EA201300121A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
JP2005537234A5 (https=)
MY188825A (en) High-concentration monoclonal antibody formulations
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
ATE494889T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
UA95488C2 (ru) Концентрированный раствор метотрексата для подкожного введения
EA201101706A1 (ru) Лекарственное средство на основе дииндолилметана(dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека
JP2013533268A5 (https=)
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
JP2016539921A5 (https=)
WO2008109119A3 (en) Wnt compositions and methods of use thereof
PL2043637T3 (pl) Sposoby i leki do podawania ibuprofenu
EA201101565A1 (ru) Способы введения и составы для лечения регионарной жировой ткани
WO2009004995A1 (ja) 生理活性物質を定着および発現させる方法
MX2009006893A (es) Composiciones farmaceuticas y metodo para el tratamiento de la inflamacion en el ganado y en otros animales.
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
WO2004112838A3 (en) Codrugs of diclofenac